Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months

South African Medical Journal

Volumn 85, Issue 12 I, 1995, Pages 1295-1298

  Ramkissoon, A ^a   Coovadia, H M ^a   Jugnundan, P ^a   Haffejee, I E ^a   Meurice, F ^a   Vandevoorde, D ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; LIVE VACCINE; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; CHICKENPOX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOFLUORESCENCE; IMMUNOGENICITY; INFANT; MALE; NORMAL HUMAN; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SKIN MANIFESTATION;

ANTIBODIES, VIRAL; CHICKENPOX VACCINE; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; SAFETY; SOUTH AFRICA; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0029561546     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)